Literature DB >> 4170381

Formal discussion: the role of transplantation in the experimental investigation of human leukemia and lymphoma.

R A Adams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4170381

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Evidence for methylation as a regulatory mechanism in HLA-DR alpha gene expression.

Authors:  M N Carrington; R D Salter; P Cresswell; J P Ting
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Evidence for chromatin structure as a regulatory determinant in HLA-DR alpha gene expression.

Authors:  J P Ting; M N Carrington; R D Salter; R DeMars; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  Proliferation stimulating effects of chrysotile and crocidolite asbestos fibres on B lymphocyte cell lines.

Authors:  A Ueki; T Oka; Y Mochizuki
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

4.  Expression of T-lymphoblast-encoded HLA-DR antigens on human T-B lymphoblast hybrids.

Authors:  D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Human T-B lymphoblast hybrids express HLA-DR specificities not expressed by either parent.

Authors:  D N Howell; A E Berger; P Cresswell
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

6.  The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif.

Authors:  C G Begley; P D Aplan; S M Denning; B F Haynes; T A Waldmann; I R Kirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Comparison of cellular basis of drug sensitivity of human colon, pancreatic, and renal carcinoma cell lines with that of leukemia cell lines.

Authors:  S Ozawa; T Yasuda; M Inaba
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Transcription of HLA class II genes in the absence of B-cell-specific octamer-binding factor.

Authors:  E Stimac; S Lyons; D Pious
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.